Cancer test kit

for genestissue

The 21 genes include 16 breast cancer-related genes in the proliferation group, invasion group, HER2 group, estrogen group and other groups, and 5 reference genes in the reference genome. 【expected usage】 This kit is used to detect the expression of 21 genes in the tumor tissues of breast cancer patients and calculate the recurrence score (RS) to assist doctors in the hormone receptor-positive, axillary lymph node negative or axillary lymph node metastasis ≤ 2mm( 2011NCCN China) assesses the risk of recurrence in breast cancer patients after surgery, and predicts the sensitivity of patients to tamoxifen or tamoxifen combined with chemotherapy. 【Product advantages】 It is used to detect the expression of 21 genes in the tumor tissues of breast cancer patients and calculate the recurrence score (RS) to assist doctors in the operation of breast cancer patients with hormone receptor positive, axillary lymph node negative, or axillary lymph node micrometastasis Post-recurrence risk assessment, and predict the sensitivity of patients to tamoxifen or tamoxifen combined with chemotherapy, so that nearly 30% of breast cancer patients will be free from chemotherapy